CN101843690B - Chinese medicament for treating osteoporosis - Google Patents

Chinese medicament for treating osteoporosis Download PDF

Info

Publication number
CN101843690B
CN101843690B CN2009100937070A CN200910093707A CN101843690B CN 101843690 B CN101843690 B CN 101843690B CN 2009100937070 A CN2009100937070 A CN 2009100937070A CN 200910093707 A CN200910093707 A CN 200910093707A CN 101843690 B CN101843690 B CN 101843690B
Authority
CN
China
Prior art keywords
radix
chinese medicine
parts
chinese
fine powder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2009100937070A
Other languages
Chinese (zh)
Other versions
CN101843690A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wei Dezong
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2009100937070A priority Critical patent/CN101843690B/en
Publication of CN101843690A publication Critical patent/CN101843690A/en
Application granted granted Critical
Publication of CN101843690B publication Critical patent/CN101843690B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a Chinese medicament for treating osteoporosis, and belongs to the field of Chinese medicaments for treating orthopedic diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: eucommia bark, Chinese angelica, radix pseudo-ginseng, rehmannia glutinosa, lucid ganoderma, twotooth achyranthes root, dogwood and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, tonifying bone and engendering marrow, and tonifying kidney and relieving pain, and has the advantages of obvious effect, exact medicinal effect and quick response.

Description

The osteoporotic Chinese medicine of a kind of treatment
Technical field
The invention belongs to the field of Chinese medicines of treatment orthopaedic disease.
Background technology
Present be intended to treat the osteoporotic field of Chinese medicines, exist the deficiency of two aspects: the one, effect is obvious inadequately, and the 2nd, it is slower to take effect.So that sufferers of osteoporosis face are owing to can not get the treatment of active drug for a long time in a large number, the state of an illness constantly develops, and the bone amount reduces, and bone strength weakens, and osteodynia is serious, easily fractures, and patient and family members thereof are very dissatisfied to this.
At problem set forth above, the invention provides the osteoporotic Chinese medicine of a kind of treatment, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, the osteoporotic Chinese medicine of a kind of treatment adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
The Cortex Eucommiae 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
Radix Rehmanniae Preparata 5---30 parts of 40 portions of Ganodermas 2---12 parts of Radix Achyranthis Bidentataes 4---
Fructus Corni 4---30 parts
The osteoporotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Cortex Eucommiae, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Fructus Corni are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.The traditional Chinese medical science is thought, all diseases of osteoporosis are sick at bone, control from kidney.Give birth to marrow so mend bone with the Cortex Eucommiae; Radix Rehmanniae Preparata, Fructus Corni kidney tonifying, essence replenishing are with the energy of hypertrophy bone; Be aided with Ganoderma, Radix Angelicae Sinensis, Radix Notoginseng benefiting QI and nourishing blood, promoting blood circulation, removing blood stasis and relieving pain; Radix Achyranthis Bidentatae the kidney invigorating pain relieving.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling is mended bone and is given birth to marrow, and the merit of the kidney invigorating pain relieving is effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Cortex Eucommiae 50 gram Radix Angelicae Sinensis 80 gram Radix Notoginseng 60 grams
Radix Rehmanniae Preparata 100 kairine sesames 40 gram Radix Achyranthis Bidentataes 80 grams
Fructus Corni 80 grams
Weight in accordance with regulations, with conventional water extraction process the Cortex Eucommiae, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Fructus Corni are extracted, make extractum fine powder 126 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 807 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Cortex Eucommiae 160 gram Radix Angelicae Sinensis 160 gram Radix Notoginseng 100 grams
Radix Rehmanniae Preparata 200 kairine sesames 60 gram Radix Achyranthis Bidentataes 160 grams
Fructus Corni 160 grams
By above-mentioned same method, make 1471 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Cortex Eucommiae 300 gram Radix Angelicae Sinensis 300 gram Radix Notoginseng 200 grams
Radix Rehmanniae Preparata 400 kairine sesames 120 gram Radix Achyranthis Bidentataes 300 grams
Fructus Corni 300 grams
By above-mentioned same method, make 2857 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
4 parts of 6 portions of Radix Notoginseng of 6 parts of Radix Angelicae Sinensis of the Cortex Eucommiae
6 parts of 3 parts of Radix Achyranthis Bidentataes of 7 portions of Ganodermas of Radix Rehmanniae Preparata
6 parts of Fructus Corni
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
15 parts of 25 portions of Radix Notoginseng of 25 parts of Radix Angelicae Sinensis of the Cortex Eucommiae
25 parts of 9 parts of Radix Achyranthis Bidentataes of 30 portions of Ganodermas of Radix Rehmanniae Preparata
25 parts of Fructus Corni
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science osteoporosis, through 12 routine clinical observations.Selecting the tcm diagnosis osteoporosis is standard: have a delicate constitution limb adynamia; Ache all over the body---lumbago and backache, hipbone pain, gonalgia, thorax pain, vertebrae percussion pain, height shortens, hunch, difficulty in walking.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 1 example, women's 11 examples do not have other serious disease, and the age is 52 years old-75 years old, 70.6 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and limbs are strong, and osteodynia is obviously alleviated from head to foot; The bone amount increases, and locomotor activity is better recovered.
2, effective: body constitution strengthens, and limbs are strong, and osteodynia is alleviated to some extent from head to foot; Locomotor activity is necessarily recovered.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 6 months, is a course of treatment.Instructions of taking: every day 3 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.12 philtrums of clinical experiment, produce effects 6 people, effective 5 people, invalid 1 people, total effective rate 91.6%.

Claims (1)

1. the osteoporotic Chinese medicine of treatment is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
The Cortex Eucommiae 4---20 parts of 30 parts of Radix Angelicae Sinensis 4---30 portions of Radix Notoginseng 3---
Radix Rehmanniae Preparata 5---30 parts of 40 portions of Ganodermas 2---12 parts of Radix Achyranthis Bidentataes 4---
Fructus Corni 4---30 parts
The osteoporotic Chinese medicine of this treatment is made by following method:
(1) by above-mentioned weight ratio, the Cortex Eucommiae, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Radix Achyranthis Bidentatae, Fructus Corni are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, make Chinese medicine granules, powder, capsule, watered pill, Tabules.
CN2009100937070A 2009-09-25 2009-09-25 Chinese medicament for treating osteoporosis Expired - Fee Related CN101843690B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100937070A CN101843690B (en) 2009-09-25 2009-09-25 Chinese medicament for treating osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100937070A CN101843690B (en) 2009-09-25 2009-09-25 Chinese medicament for treating osteoporosis

Publications (2)

Publication Number Publication Date
CN101843690A CN101843690A (en) 2010-09-29
CN101843690B true CN101843690B (en) 2011-08-17

Family

ID=42768626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100937070A Expired - Fee Related CN101843690B (en) 2009-09-25 2009-09-25 Chinese medicament for treating osteoporosis

Country Status (1)

Country Link
CN (1) CN101843690B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272119A (en) * 2013-05-03 2013-09-04 甘肃中脉生物医药科技有限公司 Traditional Chinese medicine preparation for treating osteoporosis
CN106361947A (en) * 2016-11-07 2017-02-01 成都泠汐尚品科技有限公司 Preparation method of traditional Chinese medicine for treating osteoporosis
CN106344686A (en) * 2016-11-07 2017-01-25 成都泠汐尚品科技有限公司 Method for making traditional Chinese medicine for strengthening muscles and bones
CN108465031A (en) * 2018-05-03 2018-08-31 佛山科学技术学院 A kind of Chinese medicine composition and preparation method thereof for treating osteoporosis

Also Published As

Publication number Publication date
CN101843690A (en) 2010-09-29

Similar Documents

Publication Publication Date Title
CN101843787A (en) Chinese medicament for treating benign prostatic hyperplasiabrain
CN101843690B (en) Chinese medicament for treating osteoporosis
CN101564462B (en) Chinese medicament for treating diabetic osteoporosis
CN101518611B (en) Traditional Chinese medicine for treating bone tumor
CN101862398B (en) Chinese medicament for treating osteoporosis
CN101843739B (en) Oral Chinese medicament for treating fracture
CN101843731B (en) Chinese medicament for treating femoral head necrosis
CN101843741B (en) Chinese medicament for treating femoral head necrosis
CN101843759B (en) Oral Chinese medicament for treating fracture
CN101843698B (en) Chinese medicament for treating cervical spondylosis
CN101843705B (en) Chinese medicament for treating lupus erythematosus
CN101843679B (en) Chinese medicament for treating cervical spondylosis
CN101850018A (en) Chinese medicament for treating cervical spondylosis
CN101843708B (en) Chinese medicament for treating cervical spondylosis
CN101850055B (en) Chinese medicament for treating coronary heart diseases
CN101843691B (en) Chinese medicament for treating femoral head necrosis
CN101843798B (en) Oral Chinese medicament for treating fracture
CN101843716B (en) Chinese medicament for treating femoral head necrosis
CN101843710B (en) Chinese medicament for treating femoral head necrosis
CN101843749A (en) Chinese medicament for treating femoral head necrosis
CN101843729B (en) Chinese medicament for treating cervical spondylosis
CN101843799B (en) Oral Chinese medicament for treating fracture
CN101879245A (en) Traditional Chinese medicine for treating femoral head necrosis
CN101879246A (en) Traditional Chinese medicine for treating lupus erythematosus
CN101843797A (en) Chinese medicament for treating pulmonary heart diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: WEI DEZONG

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20141218

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 541105 GUILIN, GUANGXI ZHUANG AUTONOMOUS REGION

TR01 Transfer of patent right

Effective date of registration: 20141218

Address after: 541105, room 2, unit 8, 1 Xing Xing Road, 202 Town, Lingui County, the Guangxi Zhuang Autonomous Region, Lingui

Patentee after: Wei Dezong

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

DD01 Delivery of document by public notice

Addressee: Wei Dezong

Document name: Notification to Pay the Fees

DD01 Delivery of document by public notice
DD01 Delivery of document by public notice

Addressee: Wei De Zong

Document name: Notification of Termination of Patent Right

DD01 Delivery of document by public notice
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110817

Termination date: 20180925

CF01 Termination of patent right due to non-payment of annual fee